Functional Studies of the Na,K-ATPase

Na,K-ATP酶的功能研究

• 批准号: 7101010
• 负责人: JERRY B LINGREL
• 金额: $ 37.47万
• 依托单位: UNIVERSITY OF CINCINNATI
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-01-01 至 2010-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7101010
• 关键词: adrenocorticotropic hormone; animal breeding; binding sites; cardiac glycosides; chemotherapy; chimeric proteins; congestive heart failure; enzyme activity; enzyme mechanism; genetically modified animals; heart function; hypertension; isozymes; laboratory mouse; ouabain; protein structure function; sodium potassium exchanging ATPase; telemetry; tissue /cell culture

DESCRIPTION (provided by applicant): This application proposes to continue our studies of the Na,K-ATPase and is directed toward several ongoing goals. One of these is to test whether the cardiac glycoside binding site of the alpha2 or alpha3 isoforms of this enzyme, which is highly conserved among species, plays a biological role. Such studies will provide insight as to whether endogenous cardiac glycosides such as endogenous ouabain observed by many laboratories is physiologically significant. Another objective is to define the role of the alpha2 isoform in heart and vascular smooth muscle by analyzing tissue-specific alpha2 isoform knockout animals. The specific aims of our grant are (1) To determine whether the cardiac glycoside binding site of the Na,K-ATPase has biological significance and whether endogenous cardiac glycosides play a physiological role. To accomplish this, genetically engineered mice expressing either ouabain-resistant alpha2 or alpha3 isoforms will be analyzed under conditions known to increase the levels of endogenous cardiac glycosides such as ACTH-induced hypertension. If the ouabain-resistant mice respond differently from wild type animals, this will suggest a physiological role for endogenous ouabain. However, if mice with ouabain resistant alpha2 or alpha3 isoforms respond similarly to wild type animals, this will detract from the hypothesis that endogenous cardiac glycosides have physiological significance. (2) To define the specific role of the alpha2 isoform using tissuespecific knockouts. We have already developed mice where the alpha2 isoform gene is flanked by loxP sites and we have mated these to animals carrying Cre-recombinase under the control of a cardiac-specific promoter. We will now mate the alpha2 isoform loxP animals with those expressing Cre-recombinase under the control of a smooth muscle promoter. These matings will provide animals where the alpha2 isoform is missing only in heart or smooth muscle and this will allow us to study the specific role of this isoform in cardiovascular function.

描述（由申请人提供）：本申请建议继续我们对Na，K-ATP酶的研究，并针对几个正在进行的目标。其中之一是测试该酶的α 2或α 3亚型的强心苷结合位点是否发挥生物学作用，该位点在物种之间高度保守。这些研究将为许多实验室观察到的内源性强心苷（如内源性哇巴因）是否具有生理学意义提供见解。另一个目的是通过分析组织特异性α 2亚型敲除动物来确定α 2亚型在心脏和血管平滑肌中的作用。本项目的具体目的是：（1）确定Na，K-ATP酶的强心苷结合位点是否具有生物学意义，以及内源性强心苷是否发挥生理作用。为了实现这一点，将在已知增加内源性强心苷水平（如ACTH诱导的高血压）的条件下分析表达哇巴因抗性α 2或α 3亚型的基因工程小鼠。如果哇巴因抗性小鼠的反应与野生型动物不同，这将表明内源性哇巴因的生理作用。然而，如果具有哇巴因抗性α 2或α 3同种型的小鼠与野生型动物相似地响应，则这将偏离内源性强心苷具有生理意义的假设。(2)使用组织特异性敲除来定义α 2亚型的具体作用。我们已经开发出了小鼠，其中alpha 2亚型基因两侧是loxP位点，我们已经将这些小鼠与携带Cre重组酶的动物交配，这些重组酶在心脏特异性启动子的控制下。我们现在将α 2同种型loxP动物与在平滑肌启动子控制下表达Cre重组酶的动物交配。这些交配将提供仅在心脏或平滑肌中缺失α 2亚型的动物，这将使我们能够研究这种亚型在心血管功能中的特定作用。